Joint pain from cancer drug measured in new study

NCT ID NCT03455907

Completed Knowledge-focused Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at how often joint pain occurs in 71 people with ovarian, colorectal, or lung cancer who were taking the drug bevacizumab. Participants filled out a questionnaire about their joint pain over 6 months. The goal was to better understand this side effect.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: bevacizumab
What this could lead to: If successful, this study could help doctors better understand and manage joint pain as a side effect of bevacizumab in cancer patients.
What could go wrong: This is a small, completed observational survey, not a treatment trial. It only measures how often joint pain happens, not whether it can be prevented or cured.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTHRALGIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Arthralgia colorectal cancer lung cancer ovarian cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARTHRALGIA

Contacts and locations

Locations

Centre Oscar Lambret

Lille, France
Hôpital Huriez. CHRU

Lille, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.